Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juneko E Grilley-Olson

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Future Oncology (London, England)|December 9, 2017
Can we predict the response to therapy in soft tissue sarcoma?Danielle File, Juneko E Grilley-Olson
Current Treatment Options in Oncology|February 2, 2023
A League of Its Own? Established and Emerging Therapies in Undifferentiated Pleomorphic SarcomaLaurie Graves, William R Jeck, Juneko E Grilley-Olson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2010
If histology mattersThomas E Stinchcombe, Juneko E Grilley-Olson, Mark A Socinski
Annals of Surgical Oncology|August 5, 2025
ASO Author Reflections: Circulating Tumor DNA as a Potential Emerging Biomarker in Malignant Phyllodes TumorsLaura H Rosenberger, Ellery H Reason, Juneko E Grilley-Olson
The American Journal of Dermatopathology|November 6, 2020
Immune Checkpoint Markers in Superficial Angiosarcomas: PD-L1, PD-1, CD8, LAG-3, and Tumor-Infiltrating LymphocytesPaul B Googe, Kyle Flores, Francie Jenkins, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Multidisciplinary Management of Oligometastatic Soft Tissue SarcomaJuneko E Grilley-Olson, Nicholas P Webber, David S Demos, et al.
The Oncologist|January 25, 2015
A randomized phase II study of carboplatin with weekly or every-3-week nanoparticle albumin-bound paclitaxel (abraxane) in patients with extensive-stage small cell lung cancerJuneko E Grilley-Olson, Vicki L Keedy, Alan Sandler, et al.
Journal of Adolescent and Young Adult Oncology|May 19, 2021
Health Insurance Payer Type and Ethnicity Are Associated with Cancer Clinical Trial Enrollment Among Adolescents and Young AdultsRebecca D Sullenger, Allison M Deal, Juneko E Grilley Olson, et al.
Current Oncology Reports|October 11, 2025
Management of Desmoid TumorsJuneko E Grilley-Olson, Gina Sotolongo, William R Jeck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2020
A Phase 1b Dose Escalation Trial of NC-6300 (Nanoparticle Epirubicin) in Patients with Advanced Solid Tumors or Advanced, Metastatic, or Unresectable Soft-tissue SarcomaSant P Chawla, Sanjay Goel, Warren Chow, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Future Oncology (London, England)|December 9, 2017
Can we predict the response to therapy in soft tissue sarcoma?Danielle File, Juneko E Grilley-Olson
Current Treatment Options in Oncology|February 2, 2023
A League of Its Own? Established and Emerging Therapies in Undifferentiated Pleomorphic SarcomaLaurie Graves, William R Jeck, Juneko E Grilley-Olson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2010
If histology mattersThomas E Stinchcombe, Juneko E Grilley-Olson, Mark A Socinski
Annals of Surgical Oncology|August 5, 2025
ASO Author Reflections: Circulating Tumor DNA as a Potential Emerging Biomarker in Malignant Phyllodes TumorsLaura H Rosenberger, Ellery H Reason, Juneko E Grilley-Olson
The American Journal of Dermatopathology|November 6, 2020
Immune Checkpoint Markers in Superficial Angiosarcomas: PD-L1, PD-1, CD8, LAG-3, and Tumor-Infiltrating LymphocytesPaul B Googe, Kyle Flores, Francie Jenkins, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Multidisciplinary Management of Oligometastatic Soft Tissue SarcomaJuneko E Grilley-Olson, Nicholas P Webber, David S Demos, et al.
The Oncologist|January 25, 2015
A randomized phase II study of carboplatin with weekly or every-3-week nanoparticle albumin-bound paclitaxel (abraxane) in patients with extensive-stage small cell lung cancerJuneko E Grilley-Olson, Vicki L Keedy, Alan Sandler, et al.
Journal of Adolescent and Young Adult Oncology|May 19, 2021
Health Insurance Payer Type and Ethnicity Are Associated with Cancer Clinical Trial Enrollment Among Adolescents and Young AdultsRebecca D Sullenger, Allison M Deal, Juneko E Grilley Olson, et al.
Current Oncology Reports|October 11, 2025
Management of Desmoid TumorsJuneko E Grilley-Olson, Gina Sotolongo, William R Jeck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2020
A Phase 1b Dose Escalation Trial of NC-6300 (Nanoparticle Epirubicin) in Patients with Advanced Solid Tumors or Advanced, Metastatic, or Unresectable Soft-tissue SarcomaSant P Chawla, Sanjay Goel, Warren Chow, et al.
Pageof 5